AUPH Q1 2021 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

AUPHAurinia Pharmaceuticals Inc.

$2B

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$914,000+2946.7% YoY

Gross Profit

$866,00094.7% margin

Operating Income

-$51M-5529.9% margin

Net Income

-$50M-5511.9% margin

EPS (Diluted)

$-0.40

QoQ Revenue Growth

-98.2%

Cash Flow

Operating Cash Flow

-$54M

Free Cash Flow

-$55M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$417M

Total Liabilities

$47M

Stockholders' Equity

$370M

Cash & Equivalents

$157M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$914,000	$30,000	+2946.7%
Gross Profit	$866,000	$30,000	+2786.7%
Operating Income	-$51M	-$27M	-86.8%
Net Income	-$50M	-$26M	-94.3%

Revenue Segments

License

$884,00097%

Product

$30,0003%